Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock transcription factor 5 (HSF5)
- Target
- HSF5
- Molecular classification
- Transcription factor, Heat shock transcription factor family, DNA-binding protein
01
Overview
Heat shock transcription factor 5 (HSF5) is a member of the heat shock factor family of transcription factors and is characterized by a winged-helix-turn-helix DNA-binding domain. Unlike canonical HSFs such as HSF1, HSF5 lacks specific heptad repeats required for trimerization. HSF5 is predominantly expressed in the testis, where it is critical for the progression of meiotic prophase in spermatocytes and the successful completion of spermatogenesis under non-stress conditions. Its disruption leads to meiotic arrest and male infertility. HSF5 binds unique DNA motifs, partly distinct from other HSFs, and is a regulator of genes involved in chromatin organization and the meiotic program. HSF5 has emerging relevance as a biomarker for testicular function and cancer prognosis[1][2][3][4][5][7].
- Other names
- Heat shock factor protein 5HSF5HSTF5FLJ40311HSF 5HSTF 5heat shock transcription factor family member 5
02
Mechanism of action
Not applicable; HSF5 is not currently a direct target of any approved drugs. Theoretically, a drug would modulate its transcription factor activity or DNA binding.
03
Biological functions
Regulation of gene expression in male germ cell meiosis and spermatogenesisBinding specific DNA motifs to control transcriptionEssential for pachytene transition during meiotic prophase in spermatogenesisChromatin organizationTranscriptional regulation of heat shock proteins and meiosis-specific genes
04
Disease associations
Male infertility (essential for male fertility; disruption leads to meiotic arrest in spermatocytes)Cancer, especially as a prognostic biomarker in lung adenocarcinomaPotential involvement in other developmental and pathological processes via heat shock transcription factor network
05
Safety considerations
No specific drug safety concerns known, as there are no HSF5-targeted drugs. However, disruption of HSF5 leads to male infertility, suggesting that targeting this factor could adversely affect spermatogenesis and fertility
06
Biomarkers
HSF5 expression has been studied as a prognostic biomarker in lung adenocarcinomaHSF5 expression as a marker for testicular germ cell health and meiotic progression
Beyond the preview
Go deeper on Heat shock transcription factor 5 (HSF5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heat shock transcription factor 5 (HSF5).